TY - JOUR
T1 - The influence of the SARS-CoV-2 pandemic on esophagogastric cancer services:
T2 - An international survey of esophagogastric surgeons
AU - Kamarajah, Sivesh K
AU - Markar, Sheraz R
AU - Singh, Pritam
AU - Griffiths, Ewan A
AU - Oesophagogastric Anastomosis Audit Group
AU - Nieponice, Alejandro
AU - Quesada, Bernabe M. Q
AU - Daneri, Gustavo A.
AU - Foley, Daniel
AU - Mitchell, David
AU - Watson, David
AU - Kohn, Geoffrey P
AU - Shimokawa, Kontoku
AU - Hii, Michael
AU - Talbot, Michael
AU - Merrett, Neil
AU - Cashin, Paul
AU - Townend, Phillip J.
AU - Finch, Robert
AU - Jacobs, Rod
AU - Gananadha, Sivakumar
AU - Bright, Tim
AU - Hill, Vanessa
AU - Öfner-Velano, Dietmar
AU - Vandaele, Elke
AU - Depypere, Lieven
AU - deMaat, Michiel deMaat
AU - Mandeville, Yannick
AU - Lourenco, Laercio G.
AU - Moreira, Luis F.
AU - Lourenco, Laercio G.
AU - Furtado, Wendel
AU - Alegbeleye, Bamidele J.
AU - Kidane, Biniam
AU - Johnston, Brian
AU - French, Daniel G.
AU - Ferri, Lorenzo
AU - Coburn, Natalie
AU - Rosero, German A.
AU - Vargas, Jota
AU - Guevarac, Raul
AU - Faltova, Hana
AU - Ainsworth, Alan
AU - Kjaer, Daniel W.
AU - Barbary, Mohabel
AU - Shetiwy, Mosab
AU - Ez, Reda
AU - Kechagias, Aristotelis
AU - Brigand, Cecile
AU - Collet, Denis
AU - Piessen, Guillaume
AU - Chirica, Mircea
AU - Glehen, Olivier
AU - Cattan, Pierre
AU - Msika, Simon
AU - Djourno, Xavier
AU - Novotny, Alexander
AU - Mueller, Beat
AU - Reim, Daniel
AU - Herzberg, Jonas
AU - Reichert, Martin
AU - Biebl, Matthias
AU - Reeh, Matthias
AU - Grimminger, Peter
AU - Boddy, Alex
AU - Baker, Andrew
AU - Cowie, Andrew
AU - Chaudhry, Asif
AU - Alkhaffaf, Bilal
AU - Peters, Christopher
AU - Titcomb, Daniel
AU - Bowrey, David J.
AU - Cheong, Edward
AU - Griffiths, Ewen A.
AU - Noble, Fergus
AU - van Workum, Frans
AU - Macaulay, Graeme D
AU - Kelly, Jamie
AU - Dawas, Khalid
AU - Wadley, Martin
AU - Forshaw, Matthew
AU - Navidi, Maziar
AU - Tewari, Nila
AU - Tucker, Olga
AU - Leeder, Paul
AU - Wilkerson, Paul
AU - Jambulingam, Periyathambi
AU - Singh, Pritam
AU - Vohra, Ravinder
AU - Kennedy, Ray
AU - Gopalarao, Rohith
AU - Jaunoo, Shameen
AU - Dwerryhouse, Simon
AU - McNally, Stephen
AU - Adil, Tanveer
AU - Underwood, Timothy J.
AU - Jagadesham, Vamshi
AU - Al-Khyatt, Waleed
AU - Viswanath, YKS
AU - Mastoraki, Aikaterini
AU - Charalabopoulos, Alexandros
AU - Manatakis, Dimitrios
AU - Schizas, Dimitrios
AU - Theodorou, Dimitris
AU - Baili, Efstratia
AU - Christodoulidis, Gregory
AU - Ioannidis, Orestis
AU - Liakakos, Theodoros
AU - Dimitris, Zacharoulis
AU - Wong, Claudia
AU - Papp, Andras
AU - Tóth, Dezső
AU - Maruthachalam, Karthik
AU - Hamdani, Nissar H.
AU - Mahmoodzadeh, Habibollah
AU - Kennedy, Andrew J.
AU - Collins, Chris
AU - Donohoe, Claire
AU - Reynolds, John
AU - Fiorillo, Claudio
AU - Bernardi, Daniele
AU - Rosa, Fausto
AU - Mura, Gianni
AU - Sica, Giuseppe S
AU - Weindelmayer, Jacob
AU - Moletta, Lucia
AU - Angrisani, Luigi
AU - Bonavina, Luigi
AU - Migliore, Marcello
AU - Catarci, Marco
AU - Marino, Marco V.
AU - Valmasoni, Michele
AU - Rosati, Riccardo
AU - Stefano, Santi
AU - Rause, Stefano
AU - Fumagalli Romario, Uberto
AU - Baiocchi, Gianluca
AU - Murakami, Masahiko
AU - Sasako, Mitsuru
AU - Mine, Shinji
AU - Obed, Aiman
AU - Haddad, Ashraf
AU - Muhinga, Morris
AU - Hallal, Ali
AU - Sfeir, Pierre
AU - Chemaly, Rodrigue
AU - Elhadi, Muhammed
AU - Bausys, Augustinas
AU - Decker, George
AU - Azagra, Juan S.
AU - Voon, Kelvin
AU - Mahendran, Hans
AU - Shukri Bin Jahit, Mohammad
AU - Wei Jin, Wong
AU - Kosai, Nik
AU - Choong, Lau Peng
AU - Takahashi, Alberto
AU - Duranee, Sosa
AU - Wijnhoven, Bas
AU - Klarenbeek, Bastiaan
AU - Rosman, Camiel
AU - Wassenaa, EB
AU - van Nieuwenhoven, EJ
AU - Nieuwenhuijzen, Grard
AU - Stoot, Jan
AU - Haveman, Jan W.
AU - Heisterkamp, Joos
AU - van Det, Marc J.
AU - van Berge Henegouwen, Mark Ivan
AU - Luyer, Misha
AU - van Duijvendijk, Peter
AU - van Esser, S.
AU - Bouwense, Stefan
AU - Gisbertz, Suzanne S.
AU - Rossaak, Jeremy
AU - Smith, Mark
AU - Szecket, Nicholas
AU - Rossaak, Jeremy
AU - Ademola, Adeyeye
AU - Wuraola , Funmilola
AU - Tareen, Adil
AU - Jabiles, Andrés G.
AU - Zevallos, Omel
AU - Major, Piotr
AU - Polkowski, Wojciech
AU - Bernardo, Carina
AU - Santos, Jorge
AU - Freire, Jose P.
AU - Costa, Paulo
AU - Cho, In
AU - Florin, Achim
AU - Predescu, Dragos
AU - Negoi, Ionut
AU - Hoara, Petre
AU - Mikhailovich, Kiselev N.
AU - Ahmed, Saleem
AU - Gonzalez, Carlos L.
AU - Martinez, Enriquet
AU - Diezdelval, Ismael
AU - de Tomas, Jorge
AU - Galindo, Julio
AU - Alvarex, Lourdes S.
AU - Pera, Manuel
AU - Esteban, Marcos B.
AU - Trincado, Miguel T.
AU - Navarro, Mingol
AU - Núñez, Rafael M. R.
AU - Gianchandani, Rajesh
AU - Morales-Conde, Salvador
AU - Martín, Vanessa C.
AU - Domínguez, Yannko G.
AU - Mahadi, Seif
AU - Nilsson, Magnus
AU - Gutknecht, Stefan
AU - Moenig, Stefan
AU - Mantziari, Styliani
AU - Borbely, Yves
AU - Kuei, Hsu Po
AU - Guner, Ali
AU - Isik, Arda
AU - Mangancolak, Elif
AU - Faruk, Karateke
AU - Akkapulu, Nezih
AU - Yalav, Orçun
AU - Bilecik, Tuna
AU - Chang, Andrew
AU - Morse, Christopher
AU - Molena, Daniela
AU - Wood, Douglas E.
AU - Luketich, James D.
AU - Steliga, Matthew
AU - Kitano, Mio
AU - Carrott, Philip
AU - Yang, Stephen C.
AU - Litle, Virginia R.
AU - Bowne, Wilbur
AU - Khorgami, Zhamak
PY - 2020/7/1
Y1 - 2020/7/1
N2 - Background: Several guidelines to guide clinical practice among esophagogastric surgeons during the COVID-19 pandemic were produced. However, none provide reflection of current service provision. This international survey aimed to clarify the changes observed in esophageal and gastric cancer management and surgery during the COVID-19 pandemic. Methods: An online survey covering key areas for esophagogastric cancer services, including staging investigations and oncological and surgical therapy before and during (at two separate time-points-24th March 2020 and 18th April 2020) the COVID-19 pandemic were developed. Results: A total of 234 respondents from 225 centers and 49 countries spanning six continents completed the first round of the online survey, of which 79% (n = 184) completed round 2. There was variation in the availability of staging investigations ranging from 26.5% for endoscopic ultrasound to 62.8% for spiral computed tomography scan. Definitive chemoradiotherapy was offered in 14.8% (adenocarcinoma) and 47.0% (squamous cell carcinoma) of respondents and significantly increased by almost three-fold and two-fold, respectively, in both round 1 and 2. There were uncertainty and heterogeneity surrounding prioritization of patients undergoing cancer resections. Of the surgeons symptomatic with COVID-19, only 40.2% (33/82) had routine access to COVID-19 polymerase chain reaction testing for staff. Of those who had testing available (n = 33), only 12.1% (4/33) had tested positive. Conclusions: These data highlight management challenges and several practice variations in caring for patients with esophagogastric cancers. Therefore, there is a need for clear consistent guidelines to be in place in the event of a further pandemic to ensure a standardized level of oncological care for patients with esophagogastric cancers.
AB - Background: Several guidelines to guide clinical practice among esophagogastric surgeons during the COVID-19 pandemic were produced. However, none provide reflection of current service provision. This international survey aimed to clarify the changes observed in esophageal and gastric cancer management and surgery during the COVID-19 pandemic. Methods: An online survey covering key areas for esophagogastric cancer services, including staging investigations and oncological and surgical therapy before and during (at two separate time-points-24th March 2020 and 18th April 2020) the COVID-19 pandemic were developed. Results: A total of 234 respondents from 225 centers and 49 countries spanning six continents completed the first round of the online survey, of which 79% (n = 184) completed round 2. There was variation in the availability of staging investigations ranging from 26.5% for endoscopic ultrasound to 62.8% for spiral computed tomography scan. Definitive chemoradiotherapy was offered in 14.8% (adenocarcinoma) and 47.0% (squamous cell carcinoma) of respondents and significantly increased by almost three-fold and two-fold, respectively, in both round 1 and 2. There were uncertainty and heterogeneity surrounding prioritization of patients undergoing cancer resections. Of the surgeons symptomatic with COVID-19, only 40.2% (33/82) had routine access to COVID-19 polymerase chain reaction testing for staff. Of those who had testing available (n = 33), only 12.1% (4/33) had tested positive. Conclusions: These data highlight management challenges and several practice variations in caring for patients with esophagogastric cancers. Therefore, there is a need for clear consistent guidelines to be in place in the event of a further pandemic to ensure a standardized level of oncological care for patients with esophagogastric cancers.
KW - SARS-CoV-2
KW - Esophagogastric Cancer Services
KW - Esophagogastric Surgeons
KW - COVID-19
KW - Esophageal surgery
KW - Pandemic
KW - Gastric cancer
KW - Esophageal cancer
UR - http://www.scopus.com/inward/record.url?scp=85089786204&partnerID=8YFLogxK
U2 - 10.1093/dote/doaa054
DO - 10.1093/dote/doaa054
M3 - Article
SN - 1120-8694
VL - 33
SP - 1
EP - 12
JO - Diseases of The Esophagus
JF - Diseases of The Esophagus
IS - 7
ER -